Zenas BioPharma, Inc. (ZBIO) analyst actions
ZBIO analyst actions moved a median of +0.38% by the close. Rating and price-target actions on ZBIO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ZBIO overview →
11 measured ZBIO analyst action events.
Where these ZBIO analyst actions landedvs 11 measured ZBIO analyst action reactions
| Middle 50% of ZBIO analyst action reactions | -1.64% to +2.64% |
|---|---|
| Median reaction (to close) | +0.38% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 ZBIO analyst action events with a measured close landed between -1.64% and +2.64%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | -0.37% | +0.33% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | Press release | -1.58% | -0.98% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | Press release | +0.05% | -2.29% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | +0.57% | +3.02% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | Press release | +1.03% | +6.01% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | -0.18% | -4.59% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | Press release | -0.13% | +3.16% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | -1.71% | +0.38% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | -0.69% | -15.50% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | Press release | +0.69% | +1.37% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out | Press release | -1.40% | +2.26% |
Keep exploring
More ZBIO: earnings → · SEC filings → · ZBIO overview →